Trial Profile
A Single-Center, Randomized, Observer Blind, Vehicle- and Comparator-controlled Trial to Evaluate the Antipsoriatic Efficacy and Safety of Topical Formulations of C-82 in a Psoriasis Plaque Test
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs C 82 (Primary) ; Betamethasone dipropionate; Calcipotriol
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors PRISM Pharma Co
- 19 Oct 2015 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 30 Jun 2015 Planned primary completion date changed from 1 Jul 2015 to 1 Aug 2015 as reported by ClinicalTrials.gov
- 30 Jun 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov